SEC-sourced researchBeta
AYTU
AYTU BIOPHARMA, INC
Company comparison ↗
Data passport
- CIK
- 0001385818
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 5/6
- Filing date
- Sep 22, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| June 2024 | 65,183,000.0000 | Sep 23, 2025 |
| June 2025 | 66,382,000.0000 | Sep 23, 2025 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| June 2025 | 66,382,000.0000 | -13,562,000.0000 | -1,937,000.0000 | 124,177,000.0000 | — | Sep 23, 2025 |
| June 2024 | 65,183,000.0000 | -15,844,000.0000 | -1,388,000.0000 | 118,095,000.0000 | — | Sep 23, 2025 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $66.38M | June 2025 | Sep 23, 2025 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $65.18M | June 2024 | Sep 23, 2025 | 10-K |
| Net incomeNetIncomeLoss | -$13.56M | June 2025 | Sep 23, 2025 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$1.94M | June 2025 | Sep 23, 2025 | 10-K |
| Total assetsAssets | $124.18M | June 2025 | Sep 23, 2025 | 10-K |
| Total liabilities | — | — | — | — |